Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term upside. Read why MENS stock is a hold.

The Evolution of Hair Care in the Digital Age The hair care industry has undergone a remarkable transformation in recent years, evolving from simple cleansing routines to sophisticated regimens ...